Mmegi

Pharmaceuticals present $190m opportunity for growth, innovation

Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC:  VCU NEWS
Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC: VCU NEWS

A study into the potential of developing a pharmaceutical industry in the country has found that strategic investments in policy, skills development, and harnessing the country’s rich biodiversity, could transform the infant sector into a regional powerhouse.

The study was developed last year by the Botswana Investment and Trade Centre (BITC) in partnership with the European Union’s Africa RISE (Reform for Investment and Sustainable Economies) programme.

The study aims to help Botswana develop its pharmaceutical manufacturing capabilities while boosting its competitiveness at both local and regional levels. The consultancy team included three local experts from the University of Botswana who worked alongside the BITC team, reporting to a diverse reference group that validated the findings.

Editor's Comment
Get back what was stolen, and lock the door

That a single private law firm pocketed P6.5 million for just four cases, out of a total P11.1 million paid for 25 matters, reeks of a system that was not merely disorganised but open to abuse.Bayford has taken a welcome first step by telling the Public Accounts Committee the truth. Now he must act decisively to ensure it never happens again and that any money lost to wrongdoing is recovered.The figures are staggering. Whilst ordinary Batswana...

Have a Story? Send Us a tip
arrow up